Vila J - Search Results

1

Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates.

Canton R, Morrissey I, Vila J, Tato M, García-Castillo M, López Y, Gargallo-Viola D, Zsolt I. Canton R, et al. Among authors: vila j. Future Microbiol. 2018 May 1;13:3-19. doi: 10.2217/fmb-2017-0289. Future Microbiol. 2018. PMID: 29745242 Free article.

2

Prevalence of IS(Aba1) in epidemiologically unrelated Acinetobacter baumannii clinical isolates.

Ruiz M, Marti S, Fernandez-Cuenca F, Pascual A, Vila J. Ruiz M, et al. Among authors: vila j. FEMS Microbiol Lett. 2007 Sep;274(1):63-6. doi: 10.1111/j.1574-6968.2007.00828.x. Epub 2007 Jul 4. FEMS Microbiol Lett. 2007. PMID: 17610514

3

46th Interscience Conference on Antimicrobial Agents and Chemotherapy.

Vila J, Bonomo RA. Vila J, et al. Future Microbiol. 2007 Feb;2(1):9-12. doi: 10.2217/17460913.2.1.9. Future Microbiol. 2007. PMID: 17661671 No abstract available.

4

In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.

Marti S, Sánchez-Céspedes J, Alba V, Vila J. Marti S, et al. Among authors: vila j. Int J Antimicrob Agents. 2009 Feb;33(2):181-2. doi: 10.1016/j.ijantimicag.2008.08.015. Epub 2008 Nov 1. Int J Antimicrob Agents. 2009. PMID: 18977642

5

In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany.

Alba V, Urban E, Angeles Dominguez M, Nagy E, Nord CE, Palacín C, Vila J. Alba V, et al. Among authors: vila j. Int J Antimicrob Agents. 2009 Mar;33(3):272-5. doi: 10.1016/j.ijantimicag.2008.08.024. Epub 2008 Dec 17. Int J Antimicrob Agents. 2009. PMID: 19095414

6

In vitro activity of ceftobiprole against Acinetobacter baumannii clinical isolates.

Marti S, Sánchez-Céspedes J, Espinal P, Vila J. Marti S, et al. Among authors: vila j. Int J Antimicrob Agents. 2009 Sep;34(3):265-7. doi: 10.1016/j.ijantimicag.2009.03.015. Epub 2009 May 5. Int J Antimicrob Agents. 2009. PMID: 19406625

7

Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates.

Lunn AD, Fàbrega A, Sánchez-Céspedes J, Vila J. Lunn AD, et al. Among authors: vila j. Int Microbiol. 2010 Mar;13(1):15-20. doi: 10.2436/20.1501.01.107. Int Microbiol. 2010. PMID: 20890836 Free article.

8

Prudent use of antibacterial agents: are we entering in an era of infections with no effective antibacterial agents? What can we do?

Vila J, Rodríguez-Baño J, Gargallo-Viola D. Vila J, et al. Enferm Infecc Microbiol Clin. 2010 Nov;28(9):577-9. doi: 10.1016/j.eimc.2010.09.002. Enferm Infecc Microbiol Clin. 2010. PMID: 21029869 No abstract available.

9

Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.

Espinal P, Roca I, Vila J. Espinal P, et al. Among authors: vila j. Future Microbiol. 2011 May;6(5):495-511. doi: 10.2217/fmb.11.30. Future Microbiol. 2011. PMID: 21585259

10

Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance.

Cantón R, Horcajada JP, Oliver A, Garbajosa PR, Vila J. Cantón R, et al. Among authors: vila j. Enferm Infecc Microbiol Clin. 2013 Sep;31 Suppl 4:3-11. doi: 10.1016/S0213-005X(13)70126-5. Enferm Infecc Microbiol Clin. 2013. PMID: 24129283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,602 results

Search Page

Filters